Celestica, Inc (CLS) concluded trading on Thursday at a closing price of $125.02, with 4.62 million shares of worth about $577.05 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 130.83% during that period and on February 20, 2025 the price saw a loss of about -4.99%. Currently the company’s common shares owned by public are about 116.36M shares, out of which, 115.74M shares are available for trading.
Stock saw a price change of -3.33% in past 5 days and over the past one month there was a price change of 5.86%. Year-to-date (YTD), CLS shares are showing a performance of 35.45% which increased to 216.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.11 but also hit the highest price of $144.27 during that period. The average intraday trading volume for Celestica, Inc shares is 3.50 million. The stock is currently trading 1.61% above its 20-day simple moving average (SMA20), while that difference is up 15.00% for SMA50 and it goes to 75.62% higher than SMA200.
Celestica, Inc (NYSE: CLS) currently have 116.36M outstanding shares and institutions hold larger chunk of about 77.88% of that.
The stock has a current market capitalization of $14.55B and its 3Y-monthly beta is at 2.19. PE ratio of stock for trailing 12 months is 33.33, while it has posted earnings per share of $3.75 in the same period. Its PEG reads 1.66 and has Quick Ratio of 0.91 while making debt-to-equity ratio of 0.42. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLS, volatility over the week remained 6.72% while standing at 8.35% over the month.
Stock’s fiscal year EPS is expected to rise by 24.19% while it is estimated to increase by 20.10% in next year. EPS is likely to shrink at an annualized rate of 20.02% for next 5-years, compared to annual growth of 46.52% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on February 04, 2025 offering a Buy rating for the stock and assigned a target price of $140 to it. Coverage by CIBC stated Celestica, Inc (CLS) stock as a Sector outperform in their note to investors on January 31, 2025, suggesting a price target of $150 for the stock. On November 22, 2024, UBS Initiated their recommendations, while on November 05, 2024, Barclays Initiated their ratings for the stock with a price target of $91. Stock get a Buy rating from Stifel on September 09, 2024.
